SCYNEXIS Inc (SCYX)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track Share on 𝕏

Stock chart
Ticker: SCYX Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-04-28 2022-04-26 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
75,000 +38.1%
3.00
225,000 USD 		75,000 +38.1% 3.00 225,000 USD
2022-04-28 2022-04-26 B Purchase

Sukenick Scott

General Counsel

Officer
3,500 +7.0%
3.00
10,500 USD 		3,500 +7.0% 3.00 10,500 USD
2021-01-26 2021-01-22 S Sale

PERCEPTIVE ADVISORS LLC

Major owner
33,849 -1.8%
8.95
302,949 USD 		33,849 -1.8% 8.95 302,949 USD
2021-01-26 2021-01-22 S Sale

PERCEPTIVE ADVISORS LLC

Major owner
285,151 -13.5%
8.16
2,326,832 USD 		285,151 -13.5% 8.16 2,326,832 USD
2021-01-26 2021-01-21 S Sale

PERCEPTIVE ADVISORS LLC

Major owner
95,000 -4.3%
7.38
701,100 USD 		95,000 -4.3% 7.38 701,100 USD
2021-01-26 2021-01-20 S Sale

PERCEPTIVE ADVISORS LLC

Major owner
185,000 -7.7%
7.43
1,374,550 USD 		185,000 -7.7% 7.43 1,374,550 USD
2020-12-23 2020-12-21 B Purchase

ANIDO ARMANDO

Non-Executive Director
5,000 +inf%
6.25
31,250 USD 		5,000 +inf% 6.25 31,250 USD
2020-12-23 2020-12-21 B Purchase

HANHAM ANN

Non-Executive Director
3,200 +758.3%
6.25
20,000 USD 		3,200 +758.3% 6.25 20,000 USD
2020-12-23 2020-12-21 B Purchase

Francois Eric

Chief Financial Officer

Officer
600 +5.4%
6.25
3,750 USD 		600 +5.4% 6.25 3,750 USD
2020-12-23 2020-12-21 B Purchase

Tinmouth Brian Philippe

Non-Executive Director
8,000 +inf%
6.25
50,000 USD 		8,000 +inf% 6.25 50,000 USD
2020-12-23 2020-12-21 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
40,000 +57.4%
6.25
250,000 USD 		40,000 +57.4% 6.25 250,000 USD
2020-12-23 2020-12-21 B Purchase

Sukenick Scott

General Counsel

Officer
1,600 +21.3%
6.25
10,000 USD 		1,600 +21.3% 6.25 10,000 USD
2020-12-23 2020-12-21 B Purchase

Macdonald Guy

Non-Executive Director
8,000 +200.0%
6.25
50,000 USD 		8,000 +200.0% 6.25 50,000 USD
2020-12-23 2020-12-21 B Purchase

GILMAN STEVEN C

Non-Executive Director
4,000 +inf%
6.25
25,000 USD 		4,000 +inf% 6.25 25,000 USD
2020-12-23 2020-12-21 B Purchase

Angulo Gonzalez David

Chief Medical Officer

Officer
1,600 +7.2%
6.25
10,000 USD 		1,600 +7.2% 6.25 10,000 USD
2019-12-16 2019-12-12 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
166,667 +31.6%
0.90
150,000 USD 		166,667 +31.6% 0.90 150,000 USD
2019-08-22 2019-08-21 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
9,500 +1.8%
1.11
10,545 USD 		9,500 +1.8% 1.11 10,545 USD
2019-08-22 2019-08-20 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
500 +0.1%
1.11
555 USD 		500 +0.1% 1.11 555 USD
2019-08-19 2019-08-15 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
10,015 +2.0%
1.01
10,115 USD 		10,015 +2.0% 1.01 10,115 USD
2019-04-18 2019-04-17 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
25,000 +5.2%
1.63
40,750 USD 		25,000 +5.2% 1.63 40,750 USD
2019-01-14 2019-01-10 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
25,000 +5.5%
0.69
17,250 USD 		25,000 +5.5% 0.69 17,250 USD
2019-01-02 2018-12-31 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
25,000 +5.8%
0.46
11,500 USD 		25,000 +5.8% 0.46 11,500 USD
2019-01-02 2018-12-31 B Purchase

Angulo Gonzalez David

Chief Medical Officer

Officer
12,000 +10.9%
0.50
5,951 USD 		12,000 +10.9% 0.50 5,951 USD
2018-09-10 2018-09-06 B Purchase

Angulo Gonzalez David

Chief Medical Officer

Officer
7,000 +6.9%
1.27
8,890 USD 		7,000 +6.9% 1.27 8,890 USD
2018-08-27 2018-08-23 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
25,000 +6.2%
1.29
32,250 USD 		25,000 +6.2% 1.29 32,250 USD
2018-04-02 2018-03-29 B Purchase

Angulo Gonzalez David

Chief Medical Officer
6,000 +6.3%
1.36
8,160 USD 		6,000 +6.3% 1.36 8,160 USD
2018-03-12 2018-03-08 B Purchase

HASTINGS DAVID C

11,834 +59.2%
1.69
19,999 USD 		11,834 +59.2% 1.69 19,999 USD
2018-03-12 2018-03-08 B Purchase

Sukenick Scott

General Counsel
2,959 +inf%
1.69
5,001 USD 		2,959 +inf% 1.69 5,001 USD
2018-03-12 2018-03-08 B Purchase

Francois Eric

Chief Financial Officer
5,917 +31.1%
1.69
10,000 USD 		5,917 +31.1% 1.69 10,000 USD
2018-03-12 2018-03-08 B Purchase

Angulo Gonzalez David

Chief Medical Officer
14,790 +20.0%
1.69
24,995 USD 		14,790 +20.0% 1.69 24,995 USD
2018-03-12 2018-03-08 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
100,000 +32.9%
1.69
169,000 USD 		100,000 +32.9% 1.69 169,000 USD
2018-03-12 2018-03-08 B Purchase

Angulo Gonzalez David

Chief Medical Officer
7,000 +7.9%
1.39
9,730 USD 		7,000 +7.9% 1.39 9,730 USD
2017-09-25 2017-09-22 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
10,000 +3.4%
2.23
22,300 USD 		10,000 +3.4% 2.23 22,300 USD
2017-08-24 2017-08-23 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
4,993 +1.7%
1.85
9,237 USD 		4,993 +1.7% 1.85 9,237 USD
2017-08-24 2017-08-22 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
7 +0.0%
1.61
11 USD 		7 +0.0% 1.61 11 USD
2017-08-17 2017-08-15 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
10,000 +3.6%
1.61
16,100 USD 		10,000 +3.6% 1.61 16,100 USD
2017-08-14 2017-08-11 B Purchase

Angulo Gonzalez David

Chief Medical Officer
10,000 +16.1%
1.55
15,500 USD 		10,000 +16.1% 1.55 15,500 USD
2017-06-22 2017-06-21 B Purchase

HASTINGS DAVID C

20,000 +inf%
1.75
35,000 USD 		20,000 +inf% 1.75 35,000 USD
2017-05-15 2017-05-12 B Purchase

Angulo Gonzalez David

Chief Medical Officer

Officer
15,000 +31.9%
1.70
25,500 USD 		15,000 +31.9% 1.70 25,500 USD
2017-05-15 2017-05-12 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
25,000 +9.9%
1.69
42,250 USD 		25,000 +9.9% 1.69 42,250 USD
2016-12-22 2016-12-21 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
25,000 +11.1%
3.30
82,500 USD 		25,000 +11.1% 3.30 82,500 USD
2016-12-19 2016-12-16 B Purchase

Angulo Gonzalez David

Chief Medical Officer

Officer
4,000 +9.5%
3.25
13,000 USD 		4,000 +9.5% 3.25 13,000 USD
2016-09-16 2016-09-15 B Purchase

Machado Patrick

Non-Executive Director
40,000 +200.0%
2.94
117,600 USD 		40,000 +200.0% 2.94 117,600 USD
2016-07-01 2016-06-30 B Purchase

Angulo Gonzalez David

Chief Medical Officer

Officer
32,150 +363.3%
2.23
71,695 USD 		32,150 +363.3% 2.23 71,695 USD
2016-07-01 2016-06-29 B Purchase

Angulo Gonzalez David

Chief Medical Officer

Officer
4,800 +118.5%
2.18
10,464 USD 		4,800 +118.5% 2.18 10,464 USD
2016-06-28 2016-06-24 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
100,000 +80.0%
2.39
239,000 USD 		100,000 +80.0% 2.39 239,000 USD
2016-06-28 2016-06-24 B Purchase

Francois Eric

Chief Financial Officer

Officer
15,000 +inf%
2.39
35,850 USD 		15,000 +inf% 2.39 35,850 USD
2016-06-28 2016-06-24 B Purchase

Machado Clarence Patrick

Non-Executive Director
20,000 +inf%
2.39
47,800 USD 		20,000 +inf% 2.39 47,800 USD
2016-06-28 2016-06-24 B Purchase

Macdonald Guy

Non-Executive Director
40,000 +inf%
2.39
95,600 USD 		40,000 +inf% 2.39 95,600 USD
2016-05-27 2016-05-25 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
5,754 +4.8%
3.26
18,758 USD 		5,754 +4.8% 3.26 18,758 USD
2016-05-27 2016-05-25 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
246 +0.2%
3.20
787 USD 		246 +0.2% 3.20 787 USD
2016-05-27 2016-05-25 B Purchase

HANHAM ANN

Non-Executive Director
4,225 +inf%
3.64
15,379 USD 		4,225 +inf% 3.64 15,379 USD
2016-05-25 2016-05-24 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
5,500 +4.8%
3.37
18,535 USD 		5,500 +4.8% 3.37 18,535 USD
2016-05-24 2016-05-23 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
3,000 +2.7%
3.15
9,450 USD 		3,000 +2.7% 3.15 9,450 USD
2016-05-24 2016-05-20 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
4,500 +4.2%
3.14
14,130 USD 		4,500 +4.2% 3.14 14,130 USD
2016-05-20 2016-05-19 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
6,000 +6.0%
3.07
18,420 USD 		6,000 +6.0% 3.07 18,420 USD
2015-11-24 2015-11-24 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
7,733 +8.4%
6.80
52,584 USD 		7,733 +8.4% 6.80 52,584 USD
2015-11-24 2015-11-23 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
15,000 +19.4%
6.79
101,850 USD 		15,000 +19.4% 6.79 101,850 USD
2015-09-18 2015-09-15 B Purchase

Angulo Gonzalez David

Chief Medical Officer

Officer
3,000 +inf%
7.00
21,000 USD 		3,000 +inf% 7.00 21,000 USD
2015-09-02 2015-08-31 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
25,000 +47.8%
7.82
195,500 USD 		25,000 +47.8% 7.82 195,500 USD
2015-08-31 2015-08-28 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
400 +0.8%
7.15
2,860 USD 		400 +0.8% 7.15 2,860 USD
2015-08-31 2015-08-27 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
1,867 +3.7%
7.07
13,200 USD 		1,867 +3.7% 7.07 13,200 USD
2015-08-27 2015-08-26 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
25,000 +100.0%
6.98
174,500 USD 		25,000 +100.0% 6.98 174,500 USD
2015-08-27 2015-08-25 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
20,000 +400.0%
7.15
143,000 USD 		20,000 +400.0% 7.15 143,000 USD
2015-08-27 2015-08-25 B Purchase

Taglietti Marco

Chief Executive Officer

Executive Director
5,000 +inf%
7.16
35,800 USD 		5,000 +inf% 7.16 35,800 USD
2014-05-09 2014-05-07 B Purchase

F.C.P.R. Genavent

Major owner
10,000 +4.4%
10.00
100,000 USD 		10,000 +4.4% 10.00 100,000 USD
2014-05-08 2014-05-07 B Purchase

Nothias Jean-Yves

Non-Executive Director
50,000 +20.4%
10.00
500,000 USD 		50,000 +20.4% 10.00 500,000 USD
2014-05-08 2014-05-07 B Purchase

Ventech Capital II

Major owner
28,000 +7.2%
10.00
280,000 USD 		28,000 +7.2% 10.00 280,000 USD
2014-05-08 2014-05-07 B Purchase

FCPR Biotechnology Fund

Major owner
50,000 +20.4%
10.00
500,000 USD 		50,000 +20.4% 10.00 500,000 USD
2014-05-08 2014-05-07 B Purchase

ALTA BIOPHARMA PARTNERS II LP

Major owner
31,934 +231.4%
10.00
319,340 USD 		31,934 +231.4% 10.00 319,340 USD
2014-05-08 2014-05-07 B Purchase

ALTA BIOPHARMA PARTNERS II LP

Major owner
868,066 +233.0%
10.00
8,680,660 USD 		868,066 +233.0% 10.00 8,680,660 USD